These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 11448906

  • 1. Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480.
    George DJ, Halabi S, Shepard TF, Vogelzang NJ, Hayes DF, Small EJ, Kantoff PW, Cancer and Leukemia Group B 9480.
    Clin Cancer Res; 2001 Jul; 7(7):1932-6. PubMed ID: 11448906
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study.
    Bok RA, Halabi S, Fei DT, Rodriquez CR, Hayes DF, Vogelzang NJ, Kantoff P, Shuman MA, Small EJ.
    Cancer Res; 2001 Mar 15; 61(6):2533-6. PubMed ID: 11289126
    [Abstract] [Full Text] [Related]

  • 3. The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480.
    George DJ, Halabi S, Shepard TF, Sanford B, Vogelzang NJ, Small EJ, Kantoff PW.
    Clin Cancer Res; 2005 Mar 01; 11(5):1815-20. PubMed ID: 15756004
    [Abstract] [Full Text] [Related]

  • 4. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
    Chen CA, Cheng WF, Lee CN, Chen TM, Kung CC, Hsieh FJ, Hsieh CY.
    Gynecol Oncol; 1999 Aug 01; 74(2):235-40. PubMed ID: 10419737
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study.
    Taplin ME, George DJ, Halabi S, Sanford B, Febbo PG, Hennessy KT, Mihos CG, Vogelzang NJ, Small EJ, Kantoff PW.
    Urology; 2005 Aug 01; 66(2):386-91. PubMed ID: 16098367
    [Abstract] [Full Text] [Related]

  • 6. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A, Kantarjian HM, Estey EH, Giles FJ, Verstovsek S, Manshouri T, Gidel C, O'Brien S, Keating MJ, Albitar M.
    Cancer; 2002 Nov 01; 95(9):1923-30. PubMed ID: 12404286
    [Abstract] [Full Text] [Related]

  • 7. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
    Werther K, Christensen IJ, Brünner N, Nielsen HJ.
    Eur J Surg Oncol; 2000 Nov 01; 26(7):657-62. PubMed ID: 11078612
    [Abstract] [Full Text] [Related]

  • 8. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer.
    Minagawa N, Nakayama Y, Hirata K, Onitsuka K, Inoue Y, Nagata N, Itoh H.
    Anticancer Res; 2002 Nov 01; 22(5):2957-63. PubMed ID: 12530025
    [Abstract] [Full Text] [Related]

  • 9. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
    Adams J, Carder PJ, Downey S, Forbes MA, MacLennan K, Allgar V, Kaufman S, Hallam S, Bicknell R, Walker JJ, Cairnduff F, Selby PJ, Perren TJ, Lansdown M, Banks RE.
    Cancer Res; 2000 Jun 01; 60(11):2898-905. PubMed ID: 10850435
    [Abstract] [Full Text] [Related]

  • 10. Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment.
    Wu Y, Saldana L, Chillar R, Vadgama JV.
    Int J Oncol; 2002 Mar 01; 20(3):509-16. PubMed ID: 11836562
    [Abstract] [Full Text] [Related]

  • 11. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer.
    Oehler MK, Caffier H.
    Anticancer Res; 2000 Mar 01; 20(6D):5109-12. PubMed ID: 11326678
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma.
    Jacobsen J, Rasmuson T, Grankvist K, Ljungberg B.
    J Urol; 2000 Jan 01; 163(1):343-7. PubMed ID: 10604387
    [Abstract] [Full Text] [Related]

  • 13. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP, Li JD, Li MD, Ye XM, Yan WC.
    Ai Zheng; 2002 Feb 01; 21(2):181-5. PubMed ID: 12479072
    [Abstract] [Full Text] [Related]

  • 14. Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma.
    Teknos TN, Cox C, Yoo S, Chepeha DB, Wolf GT, Bradford CR, Carey TE, Fisher SG.
    Head Neck; 2002 Nov 01; 24(11):1004-11. PubMed ID: 12410536
    [Abstract] [Full Text] [Related]

  • 15. Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer.
    George DJ, Regan MM, Oh WK, Tay MH, Manola J, Decalo N, Duggan S, Dewolf WC, Kantoff PW, Bubley GJ.
    Urology; 2004 Feb 01; 63(2):327-32. PubMed ID: 14972483
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
    Bachelot T, Ray-Coquard I, Menetrier-Caux C, Rastkha M, Duc A, Blay JY.
    Br J Cancer; 2003 Jun 02; 88(11):1721-6. PubMed ID: 12771987
    [Abstract] [Full Text] [Related]

  • 17. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
    George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI.
    Clin Cancer Res; 2000 Aug 02; 6(8):3147-52. PubMed ID: 10955796
    [Abstract] [Full Text] [Related]

  • 18. Serum concentrations of vascular endothelial growth factor in vulvar cancer.
    Hefler L, Tempfer C, Obermair A, Frischmuth K, Sliutz G, Reinthaller A, Leodolter S, Kainz C.
    Clin Cancer Res; 1999 Oct 02; 5(10):2806-9. PubMed ID: 10537345
    [Abstract] [Full Text] [Related]

  • 19. Serum vascular endothelial growth factor is often elevated in disseminated cancer.
    Salven P, Mänpää H, Orpana A, Alitalo K, Joensuu H.
    Clin Cancer Res; 1997 May 02; 3(5):647-51. PubMed ID: 9815732
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer.
    Nakayama Y, Sako T, Shibao K, Okazaki K, Rempo N, Onitsuka K, Minagawa N, Akahane K, Nagashima N, Nagata N, Itoh H.
    Anticancer Res; 2002 May 02; 22(4):2437-42. PubMed ID: 12174940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.